All Events

Filter by

Event Date

Filter by Event Date

September 13 - 14, 2012
Bethesda, MD
In September 2012, a working group discussed the current understanding of hormone-induced thrombosis in women and identified critical gaps in research.
September 10 - 11, 2012
This two-day working group meeting was designed to guide future directions for implementing nutrition across the continuum of medical education and specialty training. The intended outcome was a set of recommendations to medical schools, health professional organizations, the NHLBI and other funding agencies 1) on the content and implementation of nutrition and healthy lifestyles education, training and competency testing across the continuum of medical education, and for practicing physicians and other health care providers, and 2) on integrating medical nutrition education, training and research into patient care.
September 6 - 7, 2012
In September 2012, experts from the National Institutes of Health (NIH), Department of Defense (DoD), U.S. Food and Drug Administration (FDA), Department of Veterans Affairs (VA), academia, and industry attended a workshop to discuss new findings on the risks and benefits of FDA-approved HES, which is used to treat low blood volume.
In June 2012, a working group recommended actions to advance the development and application of point-of-care (POC) technologies as tools for diagnosis and monitoring in clinical cardiovascular research.
June 14 - 15, 2012
Bethesda, MD
In June 2012, a working group explored the issues relevant to thrombosis (prevention, detection/surveillance, and treatment) in pediatric cardiology and adult congenital heart disease patients and made recommendations to improve the knowledge base in this field.
Bethesda, Maryland
In June 2012, a working group identified knowledge gaps regarding exercise training as a treatment for heart failure and suggested approaches to filling those gaps.
Bethesda, MD
In June 2012, a working group discussed current knowledge and future directions for research in prediction, prevention, and treatment of pulseless electrical activity (PEA), which is a clinical condition characterized by unresponsiveness and lack of a pulse despite organized cardiac electrical activity.
December 15 - 16, 2011
This report summarizes a December 2011 workshop at which experts recommended steps to advance research on the role of the lung microbiome in asthma, COPD, and cystic fibrosis.